Logo image
Community-acquired methicillin-resistant Staphylococcus aureus (MRSA): new issues for infection control
Journal article   Peer reviewed

Community-acquired methicillin-resistant Staphylococcus aureus (MRSA): new issues for infection control

Richard P Wenzel, Gonzalo Bearman and Michael B Edmond
International Journal of Antimicrobial Agents, Vol.30(3), pp.210-212
2007
DOI: 10.1016/j.ijantimicag.2007.04.003
PMID: 17566712

View Online

Abstract

The emergence and clonal expansion of strains of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) have created new challenges with their entrance to hospitals. The increased virulence of CA-MRSA in concert with the depressed immunity of inpatients may cause added morbidity and mortality expected from healthcare-associated infections. Questions about changing prophylactic and empirical therapy as well as the use of intravenous immunoglobulin for life-threatening infections are addressed.
Sepsis IVIg Community-acquired Staphylococcus aureus PVL

Details

Metrics

Logo image